Jianyuan Wu
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 3
- Analytical Chemistry top 10%
- Analytical chemistry methods development 4
-
- Analytical Chemistry and Chromatography 4
- Molecular Sensors and Ion Detection 3
-
- Pharmacogenetics and Drug Metabolism 4
-
- RNA modifications and cancer 4
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Peptidase Inhibition and Analysis 3
Jianyuan Wu
33 papers receiving 821 citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Infectious Diseases 252
- Analytical Chemistry 65
- Genetics 52
- Neurology 72
- Health 39
Countries citing papers authored by Jianyuan Wu
This map shows the geographic impact of Jianyuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyuan Wu more than expected).
Fields of papers citing papers by Jianyuan Wu
This network shows the impact of papers produced by Jianyuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyuan Wu. The network helps show where Jianyuan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianyuan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 48 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 32 | |
| 11 | 2022 | 3 | |
| 12 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialbreakdown → | 2021 | 192 |
| 13 | 2021 | 84 | |
| 14 | 2021 | 25 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 62 | |
| 17 | 2020 | 30 | |
| 18 | 2012 | 48 | |
| 19 | 2012 | 58 | |
| 20 | 2010 | 10 |
About Jianyuan Wu
Jianyuan Wu is a scholar working on Pharmacology, Spectroscopy and Analytical Chemistry, having authored 35 papers that have together received 831 indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Analytical chemistry methods development (4 papers), RNA modifications and cancer (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Molecular Sensors and Ion Detection (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Infectious Diseases (252 citations), Analytical Chemistry (65 citations) and Genetics (52 citations). Jianyuan Wu has collaborated with scholars based in China and Australia. Frequent co-authors include Yu‐Qi Feng, Xinghuan Wang, Jianying Huang, Chang Chen, Kezhen Yi, Lanxiang Huang, Zhi‐Guo Shi, Bi‐Feng Yuan, Jiang Yue and Busen Wang. Their work appears in journals such as Advanced Functional Materials, Chemical Communications and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.